Nephros Inc
NASDAQ:NEPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
Orell Fuessli AG
SIX:OFN
|
CH |
|
D
|
Dermapharm Holding SE
XHAM:DMP
|
DE |
|
East Japan Railway Co
TSE:9020
|
JP |
|
Ferguson Enterprises Inc
NYSE:FERG
|
US |
|
Haier Smart Home Co Ltd
SSE:600690
|
CN |
|
O
|
Oceaneering International Inc
F:OII
|
US |
|
M
|
Movado Group Inc
SWB:MV4
|
US |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
CN |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
ID |
Wall St Price Targets
NEPH Price Targets Summary
Nephros Inc
According to Wall Street analysts, the average 1-year price target for NEPH is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NEPH's stock price target?
Price Target
7.14
USD
According to Wall Street analysts, the average 1-year price target for NEPH is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.
What is the Revenue forecast for Nephros Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 2 years is 12%.
What is the Gross Profit forecast for Nephros Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 2 years is 11%.
What is the Operating Income forecast for Nephros Inc?
Projected CAGR
17%
The compound annual growth rate for Operating Income over the next 2 years is 17%.
What is the Pre-Tax Income forecast for Nephros Inc?
Projected CAGR
25%
The compound annual growth rate for Pre-Tax Income over the next 2 years is 25%.
What is the Net Income forecast for Nephros Inc?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 2 years is 18%.
